The impact of the COVID-19 pandemic on self-harm and suicidal behaviour: protocol for a living systematic review
Open Access
- 25 June 2020
- journal article
- review article
- Published by F1000 Research Ltd in F1000Research
- Vol. 9, 644
Abstract
Background: The COVID-19 pandemic has caused widespread morbidity and mortality as well as disruption to people’s lives and livelihoods around the world; this has occurred as a result of both infection with the virus itself and the health protection measures taken to curb its spread. There are concerns that rates of suicide, suicidal behaviours and self-harm may rise during and in the aftermath of the pandemic. Given the likely rapidly expanding research evidence base on the pandemic’s impact on rates of suicide, suicidal behaviours and self-harm and emerging evidence about how best to mitigate such effects, it is important that the best available knowledge is made readily available to policymakers, public health specialists and clinicians as soon as is possible. To facilitate this, we plan to undertake a living systematic review focusing on suicide prevention in relation to COVID-19. Method: Regular automated searches will feed into a web-based screening system which will also host the data extraction form for included articles. Our eligibility criteria are wide and include aspects of incidence and prevalence of suicidal behaviour, effects of exposures and effects of interventions in relation to the COVID-19 pandemic, with minimal restrictions on the types of study design to be included. The outcomes assessed will be death by suicide; self-harm or attempted suicide (including hospital attendance and/or admission for these reasons); and suicidal thoughts/ideation. There will be no restriction on study type, except for single case reports. There will be no restriction on language of publication. The review will be updated at three-monthly intervals if a sufficient volume of new evidence justifies doing so. Conclusions: Our living review will provide a regular synthesis of the most up-to-date research evidence to guide public health and clinical policy to mitigate the impact of COVID-19 on suicide. Protocol registration: PROSPERO CRD42020183326 01/05/2020Keywords
Funding Information
- NIHR Bristol Biomedical Research Centre (IS-BRC-1215-20011)
- NIHR Greater Manchester Patient Safety Translational Research Centre
- University of Bristol
- Swansea University
- National Institute for Health and Care Research (DRF-2018-11-ST2-048)
- National Institute for Health and Care Research (RM-SR-2017-09-028)
- National Institute for Health Research Applied Research Collaboration West
- Cochrane Satellite for Suicide and Self-Harm Prevention
This publication has 15 references indexed in Scilit:
- Suicide risk and prevention during the COVID-19 pandemicThe Lancet Psychiatry, 2020
- Multidisciplinary research priorities for the COVID-19 pandemic: a call for action for mental health scienceThe Lancet Psychiatry, 2020
- Occurrence, prevention, and management of the psychological effects of emerging virus outbreaks on healthcare workers: rapid review and meta-analysisBMJ, 2020
- Analysing data and undertaking meta‐analyses2019
- Living systematic review: 1. Introduction—the why, what, when, and howJournal of Clinical Epidemiology, 2017
- Living systematic reviews: 4. Living guideline recommendationsJournal of Clinical Epidemiology, 2017
- Living Systematic Reviews: An Emerging Opportunity to Narrow the Evidence-Practice GapPLOS Medicine, 2014
- Impact of 2008 global economic crisis on suicide: time trend study in 54 countriesBMJ, 2013
- A revisit on older adults suicides and Severe Acute Respiratory Syndrome (SARS) epidemic in Hong KongInternational Journal of Geriatric Psychiatry, 2008
- Updating the Accounts: Global Mortality of the 1918-1920 "Spanish" Influenza PandemicBulletin of the History of Medicine, 2002